Isoflavones regulate innate immunity and inhibit experimental colitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 6, 2009, Pages 1123-1129

  Morimoto, Masakazu ^a,b   Watanabe, Tomohiro ^a   Yamori, Masashi ^a   Takebe, Minoru ^b   Wakatsuki, Yoshio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Biotics Department   (Japan)

Author keywords

Colitis; Cytokine; Isoflavone

Indexed keywords

DAIDZEIN RICH ISOFLAVONE AGLYCONE DERIVATIVE; DEXTRAN SULFATE; DRINKING WATER; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 6; INTERLEUKIN 8; ISOFLAVONE DERIVATIVE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOAVAILABILITY; BODY WEIGHT; CELL ACTIVATION; CELL FUNCTION; CELL STIMULATION; COLITIS; COLON; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE MODEL; DOWN REGULATION; FEMALE; FUNCTIONAL ASSESSMENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; LYMPH NODE CELL; MESENTERY LYMPH NODE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY; TREATMENT DURATION; WEIGHT CHANGE;

ANIMALS; COLITIS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; INTERLEUKIN-8; ISOFLAVONES; MICE; STATISTICS, NONPARAMETRIC; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 66549105907     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05714.x     Document Type: Article

References (30)

1. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 2003 3 : 521 33.
2. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 2007 117 : 514 21.
3. Mannon PJ, Fuss IJ, Mayer L et al. Anti-interleukin-12 antibody for active Crohn's disease. N. Engl. J. Med. 2004 351 : 2069 79.
4. Ito H, Takazoe M, Fukuda Y et al. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 2004 126 : 989 96 discussion 47.
5. Strober W, Murray PJ, Kitani A, Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 2006 6 : 9 20. (Pubitemid 43279749)
6. Kawai T, Akira S. Innate immune recognition of viral infection. Nat. Immunol. 2006 7 : 131 7.
7. Herath HM, Takano-Ishikawa Y, Yamaki K. Inhibitory effect of some flavonoids on tumor necrosis factor-alpha production in lipopolysaccharide- stimulated mouse macrophage cell line J774.1. J. Med. Food 2003 6 : 365 70.
8. Kang BY, Chung SW, Kim TS. Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by parthenolide, a predominant sesquiterpene lactone in Tanacetum parthenium: involvement of nuclear factor-kappaB. Immunol. Lett. 2001 77 : 159 63.
9. Anderson JJ. Soy phytoestrogens, lipid reductions, and atherosclerosis delay in ovariectomized primates. J. Clin. Endocrinol. Metab. 2001 86 : 39 40. (Pubitemid 32109772)
10. Kapiotis S, Hermann M, Held I, Seelos C, Ehringer H, Gmeiner BM. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler. Thromb. Vasc. Biol. 1997 17 : 2868 74.
11. Smith LJ, Holbrook JT, Wise R et al. Dietary intake of soy genistein is associated with lung function in patients with asthma. J. Asthma 2004 41 : 833 43.
12. Dijsselbloem N, Vanden Berghe W, De Naeyer A, Haegeman G. Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. Biochem. Pharmacol. 2004 68 : 1171 85.
13. Verdrengh M, Jonsson IM, Holmdahl R, Tarkowski A. Genistein as an anti-inflammatory agent. Inflamm. Res. 2003 52 : 341 6.
14. Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation 2007 116 : 2553 62.
15. Hong T, Nakagawa T, Pan W et al. Isoflavones stimulate estrogen receptor-mediated core histone acetylation. Biochem. Biophys. Res. Commun. 2004 317 : 259 64.
16. Ricciotti HA, Khaodhiar L, Blackburn GL. Daidzein-rich isoflavone-aglycones for menopausal symptoms. Int. J. Gynaecol. Obstet. 2005 89 : 65 6.
17. Xu JW, Yasui N, Ikeda K et al. Isoflavones regulate secretion of leukemia inhibitory factor and transforming growth factor {beta} and expression of glycodelin in human endometrial epithelial cells. J. Endocrinol. 2008 196 : 425 33.
18. Williams KL, Fuller CR, Dieleman LA et al. Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology 2001 120 : 925 37.
19. Watanabe T, Kitani A, Murray PJ, Wakatsuki Y, Fuss IJ, Strober W. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 2006 25 : 473 85.
20. Watanabe T, Yoshida M, Shirai Y et al. Administration of an antigen at a high dose generates regulatory CD4 + T cells expressing CD95 ligand and secreting IL-4 in the liver. J. Immunol. 2002 168 : 2188 99.
21. Watanabe T, Katsukura H, Shirai Y et al. A liver tolerates a portal antigen by generating CD11c + cells, which select Fas ligand + Th2 cells via apoptosis. Hepatology 2003 38 : 403 12.
22. Kobayashi M, Kweon MN, Kuwata H et al. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J. Clin. Invest. 2003 111 : 1297 308.
23. Kris-Etherton PM, Hecker KD, Bonanome A et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 2002 113 (Suppl. 9B 71S 88S. (Pubitemid 36151834)
24. Ososki AL, Kennelly EJ. Phytoestrogens: a review of the present state of research. Phytother. Res. 2003 17 : 845 69.
25. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev. 2002 23 : 90 119. (Pubitemid 34185307)
26. Kang JL, Lee HW, Lee HS et al. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. Am. J. Respir. Crit. Care Med. 2001 164 : 2206 12.
27. Inoue N, Tamura K, Kinouchi Y et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002 123 : 86 91. (Pubitemid 34747528)
28. Kwon KH, Murakami A, Tanaka T, Ohigashi H. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem. Pharmacol. 2005 69 : 395 406. (Pubitemid 40094500)
29. Karrasch T, Kim JS, Jang BI, Jobin C. The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB(EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules. PLoS ONE 2007 2 : e596.
30. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004 118 : 229 41.